Moore Kuehn, PLLC Encourages Investors Of Allogene Therapeut...| MENAFN.COM

Saturday, 04 February 2023 03:13 GMT

Moore Kuehn, PLLC Encourages Investors Of Allogene Therapeutics, Inc. To Contact Law Firm


(MENAFN- Newsfile Corp) Moore Kuehn, PLLC Encourages Investors of Allogene Therapeutics, Inc. to Contact Law Firm

New York, New York--(Newsfile Corp. - January 25, 2023) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Allogene Therapeutics, Inc. (NASDAQ: ALLO) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you own ALLO please contact Justin Kuehn, Esq. by email at or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit .

Attorney advertising. Prior results do not guarantee similar outcomes.

Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005

(212) 709-8245



To view the source version of this press release, please visit

MENAFN25012023004218003983ID1105478551


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.